| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.006 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.13 | 0.007 |